National survey on gastroesophageal reflux disease (GERD) patients - LINEA
Study identifier:NIS-GFR-DUM-2007/3
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of the impact of abdominal fat on GERD severity and GERD frequency in general practice
Medical condition
GERD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
5084
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2008
Primary Completion Date: -
Study Completion Date: 01 Dec 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | - |
Contacts
Investigators
Principal Investigator
Alain Castaigne
AstraZeneca
